German health minister recommends fourth Covid-19 dose for under 60s

Germany's Minister of Health Karl Lauterbach on Friday recommended a fourth COVID-19 vaccine dose for people under the age of 60, contradicting the advice from a relevant national commission.

Coronavirus vaccines, booster shot
Photo: Bloomberg
ANI Europe
2 min read Last Updated : Jul 17 2022 | 6:50 AM IST

Germany's Minister of Health Karl Lauterbach on Friday recommended a fourth COVID-19 vaccine dose for people under the age of 60, contradicting the advice from a relevant national commission.

Germany's Standing Committee on Vaccination (STIKO) recommends a second COVID-19 booster shot with a mRNA vaccine, such as the Pfizer/BioNTech or Moderna, only to people aged over 70, residents in care facilities, people with immunodeficiency and medical staff.

"If someone wants to enjoy the summer and not run the risk of getting ill, then I would recommend vaccination even to younger people in consultation with their family doctor," Lauterbach told the Spiegel magazine.

A vaccine adapted to Omicron is expected to come out in late August or early September, but Lauterbach said people who are aged 60 and over "should definitely not wait for the new vaccine," as the protection they need against serious illness or death is already provided by the current vaccines.

Of the 69.4 million adults in Germany aged 18 and older, around 85 percent are vaccinated against COVID-19. About 72 percent have received one booster vaccination, while almost 9 percent have received two booster doses, according to official figures.

Although Germany is hit by a COVID-19 summer wave, its vaccination campaign remains slow. "It must not be forgotten that the most important and effective measure is and remains vaccination," said the chairman of the German association of general practitioners, Ulrich Weigeldt, who called for a renewed vaccination campaign last week.

The country's seven-day COVID-19 incidence rate on Friday stood at around 720 infections per 100,000 inhabitants, after around 700 last week, according to the Robert Koch Institute (RKI) for infectious diseases.

Since the beginning of June, the number of cases has been rising steadily. "We will have a very difficult fall," Lauterbach warned.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusGermanyCoronavirus Vaccine

First Published: Jul 17 2022 | 6:50 AM IST

Next Story